A D&C is not a treatment for ectopic pregnancy, but it can be a necessary diagnostic step before treatment begins. When doctors can’t confirm on ultrasound whether a nonviable pregnancy is inside the uterus or in a fallopian tube, a D&C helps answer that question. Without it, up to 40% of patients may be treated for an ectopic pregnancy they never actually had.
Understanding why your doctor might recommend a D&C, and what it reveals, can help make sense of a situation that often feels confusing and urgent.
Why Location Matters Before Treatment Starts
Ectopic pregnancies are treated in two main ways: a medication called methotrexate that stops pregnancy tissue from growing, or surgery to remove the pregnancy from the fallopian tube. Neither of these is a D&C, and a D&C alone cannot treat an ectopic pregnancy because the pregnancy tissue isn’t in the uterus.
The problem arises when ultrasound can’t find the pregnancy anywhere. This is called a “pregnancy of unknown location.” Your blood pregnancy hormone levels are rising or falling in a pattern that suggests the pregnancy isn’t viable, but no one can see exactly where it is. It could be a miscarriage that hasn’t fully passed yet, sitting inside the uterus. Or it could be an ectopic pregnancy developing in a fallopian tube, too small to show on imaging. These two situations require completely different treatments, and getting the answer wrong carries real consequences.
What a D&C Actually Reveals
During a D&C, a doctor removes a small amount of tissue from the lining of the uterus. That tissue is then examined under a microscope for structures called chorionic villi, which are tiny finger-like projections that form where a pregnancy implants.
If chorionic villi are found, the pregnancy was inside the uterus. It was a failed intrauterine pregnancy, and the D&C itself may be the only treatment needed. If chorionic villi are not found, the pregnancy is located somewhere else, and the diagnosis of ectopic pregnancy is confirmed. At that point, your doctor will move forward with either methotrexate or surgery.
Doctors also use the pregnancy hormone (hCG) level after the procedure as a secondary check. A drop of 15% to 20% in hCG the day after a D&C supports the conclusion that the pregnancy was intrauterine and has been resolved.
The Risk of Skipping the Diagnostic Step
Methotrexate works by blocking DNA synthesis in rapidly dividing cells. It’s effective against ectopic pregnancies, but it’s also a chemotherapy drug with significant side effects. If a pregnancy of unknown location turns out to be inside the uterus rather than ectopic, the patient receives a potent medication they never needed.
More dangerous is the reverse scenario: if a pregnancy is actually still viable and intrauterine but gets misdiagnosed as ectopic, methotrexate exposure can cause serious birth defects. Studies have linked fetal exposure to heart defects and a pattern of malformations sometimes called methotrexate embryopathy. A D&C before treatment eliminates this possibility by confirming whether or not pregnancy tissue exists in the uterus.
Research from the PMC has shown that skipping endometrial sampling before ectopic treatment led to up to 40% of patients being treated for falsely diagnosed ectopic pregnancies. That’s a striking number, and it’s the core reason many clinicians advocate for routine D&C in cases where the pregnancy location is genuinely uncertain.
When a D&C Is Not Needed
If your ectopic pregnancy has already been confirmed on ultrasound, with a visible mass or gestational sac outside the uterus, there’s no diagnostic mystery to solve. In that case, treatment moves directly to methotrexate or surgery depending on several factors: the size of the ectopic pregnancy, your hCG level, and whether you’re experiencing symptoms like significant pain or internal bleeding.
Methotrexate is typically an option when hCG levels are below 5,000 mIU/mL and the ectopic mass is smaller than 4 centimeters. Above those thresholds, or if the tube has ruptured, surgery becomes necessary. The two surgical approaches are salpingectomy (removing the affected fallopian tube entirely) and salpingostomy (opening the tube and removing only the ectopic tissue while preserving the tube). The choice between them depends on the extent of damage and your plans for future pregnancies.
What Each Path Looks Like for Recovery
If you have a diagnostic D&C and chorionic villi are found, you may need nothing more than follow-up blood tests to confirm your hCG levels are dropping to zero. The procedure itself is short, typically performed under sedation, and most people recover physically within a few days.
If the D&C confirms an ectopic pregnancy and you’re treated with methotrexate, expect a longer monitoring period. Your hCG levels will be checked weekly, and it takes an average of about 34 days for levels to become undetectable, though it can take over three months in some cases. If hCG doesn’t drop by at least 25% within a week of the injection, a second dose or surgical intervention may be needed. Patients treated with methotrexate often report more physical symptoms in the first two weeks compared to those treated surgically, along with a diminished quality of life during the extended follow-up period.
Surgical recovery depends on whether the procedure is laparoscopic (minimally invasive) or open. Laparoscopic surgery generally allows a return to normal activity within one to two weeks. After salpingostomy, follow-up hCG monitoring continues until levels are undetectable, since a small amount of ectopic tissue can occasionally persist.
How hCG Trends Help Clarify the Picture
Even without a D&C, hCG patterns can sometimes point toward the right diagnosis. In a pregnancy that’s miscarrying on its own, hCG typically drops by 35% to 50% over two days, and by 66% to 87% over a week. These numbers come from a study tracking women with pregnancies of unknown location whose pregnancies resolved without intervention.
If your hCG is falling slower than those thresholds, it raises concern for an ectopic pregnancy, but it doesn’t confirm it on its own. A sluggish decline identifies someone at higher risk, not someone with a definitive diagnosis. That’s where a D&C can provide the clarity that blood work and imaging cannot. Your doctor weighs all of these factors together: the ultrasound findings, the hCG trajectory, your symptoms, and the tissue results from a D&C if one is performed.